Neurofibromatosis type 1: a single center's experience in Korea

PurposeNeurofibromatosis 1 (NF1) is an autosomal dominant condition caused by an NF1 gene mutation. NF1 is also a multisystem disorder that primarily affects the skin and nervous system. The goal of this study was to delineate the phenotypic characterization and assess the NF1 mutational spectrum in...

Full description

Bibliographic Details
Main Authors: Min Jeong Kim, Chong Kun Cheon
Format: Article
Language:English
Published: Korean Pediatric Society 2014-09-01
Series:Korean Journal of Pediatrics
Subjects:
Online Access:http://kjp.or.kr/upload/pdf/kjped-57-410.pdf
id doaj-22ad91ef7d9c4792a353da2b12481c27
record_format Article
spelling doaj-22ad91ef7d9c4792a353da2b12481c272020-11-24T23:14:28ZengKorean Pediatric SocietyKorean Journal of Pediatrics1738-10612092-72582014-09-0157941041510.3345/kjp.2014.57.9.4102014600032Neurofibromatosis type 1: a single center's experience in KoreaMin Jeong Kim0Chong Kun Cheon1Department of Pediatrics, Maryknoll Medical Center, Pusan, Korea.Department of Pediatrics, Pusan National University School of Medicine, Yangsan, Korea.PurposeNeurofibromatosis 1 (NF1) is an autosomal dominant condition caused by an NF1 gene mutation. NF1 is also a multisystem disorder that primarily affects the skin and nervous system. The goal of this study was to delineate the phenotypic characterization and assess the NF1 mutational spectrum in patients with NF1.MethodsA total of 42 patients, 14 females and 28 males, were enrolled in this study. Clinical manifestations and results of the genetic study were retrospectively reviewed.ResultsAge of the patients at the time of NF1 diagnosis was 15.8±14.6 years (range, 1-62 years). Twelve patients (28.6%) had a family history of NF1. Among the 42 patients, Café-au-lait spots were shown in 42 (100%), neurofibroma in 31 (73.8%), freckling in 22 (52.4%), and Lisch nodules in seven (16.7%). The most common abnormal finding in the brain was hamartoma (20%). Mental retardation was observed in five patients (11.9%), seizures in one patient (2.4%), and plexiform neurofibromas (PNFs) in four patients (9.5%). One patient with PNFs died due to a malignant peripheral nerve sheath tumor in the chest cavity. Genetic analysis of seven patients identified six single base substitutions (three missense and three nonsense) and one small deletion. Among these mutations, five (71.4%) were novel (two missense mutations: p.Leu1773Pro, p.His1170Leu; two nonsense mutations: p.Arg2517*, p.Cys2371*; one small deletion: p.Leu1944Phefs*6).ConclusionThe clinical characteristics of 42 Korean patients with NF1 were extremely variable and the mutations of the NF1 gene were genetically heterogeneous with a high mutation-detection rate.http://kjp.or.kr/upload/pdf/kjped-57-410.pdfNeurofibromatosis 1Neurofibromatosis 1 genesClinical characteristics
collection DOAJ
language English
format Article
sources DOAJ
author Min Jeong Kim
Chong Kun Cheon
spellingShingle Min Jeong Kim
Chong Kun Cheon
Neurofibromatosis type 1: a single center's experience in Korea
Korean Journal of Pediatrics
Neurofibromatosis 1
Neurofibromatosis 1 genes
Clinical characteristics
author_facet Min Jeong Kim
Chong Kun Cheon
author_sort Min Jeong Kim
title Neurofibromatosis type 1: a single center's experience in Korea
title_short Neurofibromatosis type 1: a single center's experience in Korea
title_full Neurofibromatosis type 1: a single center's experience in Korea
title_fullStr Neurofibromatosis type 1: a single center's experience in Korea
title_full_unstemmed Neurofibromatosis type 1: a single center's experience in Korea
title_sort neurofibromatosis type 1: a single center's experience in korea
publisher Korean Pediatric Society
series Korean Journal of Pediatrics
issn 1738-1061
2092-7258
publishDate 2014-09-01
description PurposeNeurofibromatosis 1 (NF1) is an autosomal dominant condition caused by an NF1 gene mutation. NF1 is also a multisystem disorder that primarily affects the skin and nervous system. The goal of this study was to delineate the phenotypic characterization and assess the NF1 mutational spectrum in patients with NF1.MethodsA total of 42 patients, 14 females and 28 males, were enrolled in this study. Clinical manifestations and results of the genetic study were retrospectively reviewed.ResultsAge of the patients at the time of NF1 diagnosis was 15.8±14.6 years (range, 1-62 years). Twelve patients (28.6%) had a family history of NF1. Among the 42 patients, Café-au-lait spots were shown in 42 (100%), neurofibroma in 31 (73.8%), freckling in 22 (52.4%), and Lisch nodules in seven (16.7%). The most common abnormal finding in the brain was hamartoma (20%). Mental retardation was observed in five patients (11.9%), seizures in one patient (2.4%), and plexiform neurofibromas (PNFs) in four patients (9.5%). One patient with PNFs died due to a malignant peripheral nerve sheath tumor in the chest cavity. Genetic analysis of seven patients identified six single base substitutions (three missense and three nonsense) and one small deletion. Among these mutations, five (71.4%) were novel (two missense mutations: p.Leu1773Pro, p.His1170Leu; two nonsense mutations: p.Arg2517*, p.Cys2371*; one small deletion: p.Leu1944Phefs*6).ConclusionThe clinical characteristics of 42 Korean patients with NF1 were extremely variable and the mutations of the NF1 gene were genetically heterogeneous with a high mutation-detection rate.
topic Neurofibromatosis 1
Neurofibromatosis 1 genes
Clinical characteristics
url http://kjp.or.kr/upload/pdf/kjped-57-410.pdf
work_keys_str_mv AT minjeongkim neurofibromatosistype1asinglecentersexperienceinkorea
AT chongkuncheon neurofibromatosistype1asinglecentersexperienceinkorea
_version_ 1725594207457902592